Papers

2

Total Citations

113

H-Index

2

About

No biography available yet.

Research Focus

Key Achievements

2
H-Index
2
Papers
113
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer
94 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Not generated yet